About this course

  • Released: 04/29/2014
  • Expires: 04/29/2017

 

CHRONIC MERALGIA PARESTHETICA AND NEURECTOMY: A CLINICAL PATHOLOGIC STUDY

LEARNING OBJECTIVES:

Upon completion of the article by Berini et al, the participant should be able to:

  • Discuss potential mechanisms of the development of meralgia paresthetica
  • List the findings from this study regarding pathologic analysis of nerve specimens from patients who underwent neurectomy for meralgia paresthetica and discuss the pathophysiologic  implications of the findings from this study
  • Discuss the outcomes of the patients with meralgia paresthetica who underwent neurectomy

CORE COMPETENCIES:

The article by Berini et al covers the following core competency:

  • Medical Knowledge

 

SYSTEMATIC REVIEW: EFFICACY AND SAFETY OF MEDICAL MARIJUANA IN SELECTED NEUROLOGIC DISORDERS: REPORT OF THE GUIDELINE DEVELOPMENT SUBCOMMITTEE OF THE AMERICAN ACADEMY OF NEUROLOGY

LEARNING OBJECTIVES:

Upon completion of the article by Koppel et al, the participant should be able to:

  • Discuss the pharmacology of cannabinoids and the endocannabinoid system
  • Discuss the adverse effects of medical marijuana
  • Discuss the findings from this evidence-based review regarding the efficacy and safety of cannabinoids for select neurologic conditions

CORE COMPETENCIES:

The article by Koppel et al covers the following core competency:

  • Medical Knowledge

 

AUTHOR DISCLOSURES:

Refer to Information and Author section available in the Tool Bar for each article.

 

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

CREDITS

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.

The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

DISCLOSURES

Steven Lewis, MD receives a stipend in his editorial capacity for Neurology and as an Associate Editor for Continuum: Lifelong Learning in Neurology; has received royalties for the books Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist; and anticipates receiving royalties for the book Neurologic Disorders due to Systemic Disease. James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology.

COMMERCIAL SUPPORT

This CME program receives no commercial support.

ACCME